People · Operator
Named in public records as an officer, director or promoter · active 2021–2021 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Liquidia Corp | — | Biotechnology | Series B | $21.7M | $616.9M | 2021 |
Katherine Rielly-Gauvin at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Katherine Rielly-Gauvin on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Stephen Bloch | 1 | 15 |
| David B. Johnson | 1 | 6 |
| Paul B. Manning | 1 | 6 |
| Arthur A. Kirsch | 1 | 2 |
| Michael Kaseta | 1 | 2 |
| Roger A. Jeffs | 1 | 2 |
| Joanna Horobin | 1 | 1 |
| Damian deGoa | 1 | 1 |
| Raman B. Singh | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.